Zobrazeno 1 - 10 of 39 769 pro vyhledávání: '"her2."'
1
Periodical
Targeting Cancer, Sparing Patients.
Autor: MADHUSOODANAN, JYOTI (AUTHOR)
Publikováno v: Scientific American. Mar2024, Vol. 330 Issue 3, p36-41. 6p. 1 Diagram, 1 Cartoon or Caricature.
Zobrazit plný text záznamu
2
Akademický článek
Expression Profiling Identified TRPM7 and HER2 as Potential Targets for the Combined Treatment of Cancer Cells.
Autor: Egawa, Miyuki1 (AUTHOR) miyuki.egawa@campus.lmu.de, Schmücker, Eva1 (AUTHOR) eva_schmuecker@gmx.de, Grimm, Christian1,2 (AUTHOR) christian.grimm@med.uni-muenchen.de, Gudermann, Thomas1,3 (AUTHOR) thomas.gudermann@lrz.uni-muenchen.de, Chubanov, Vladimir1 (AUTHOR) thomas.gudermann@lrz.uni-muenchen.de
Publikováno v: Cells (2073-4409). Nov2024, Vol. 13 Issue 21, p1801. 20p.
Zobrazit plný text záznamu
3
Akademický článek
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study.
Autor: Chen, Yan1,2 (AUTHOR) cy1125coconut@163.com, Qiu, Yu1,2 (AUTHOR) qiuyu19981204@163.com, Shen, Haoyang1,2 (AUTHOR) shenhy0229@163.com, Yan, Shuixin1,2 (AUTHOR) 18857427548@163.com, Li, Jiadi1,2 (AUTHOR) lijiadi970327@163.com, Wu, Weizhu1 (AUTHOR) wuweizhu1128@163.com
Publikováno v: BMC Women's Health. 12/31/2024, Vol. 24 Issue 1, p1-16. 16p.
Zobrazit plný text záznamu
4
Akademický článek
Current and future immunotherapy for breast cancer.
Autor: Heater, Natalie K.1 (AUTHOR), Warrior, Surbhi2 (AUTHOR), Lu, Janice2 (AUTHOR) Janice.lu@northwestern.edu
Publikováno v: Journal of Hematology & Oncology. 12/25/2024, Vol. 17 Issue 1, p1-63. 63p.
Zobrazit plný text záznamu
5
Akademický článek
Author Correction: Leveraging ML for profiling lipidomic alterations in breast cancer tissues: a methodological perspective.
Autor: Shahnazari, Parisa1,2 (AUTHOR), Kavousi, Kaveh1,2 (AUTHOR), Minuchehr, Zarrin3 (AUTHOR), Goliaei, Bahram4 (AUTHOR) goliaei@ut.ac.ir, Salek, Reza M.5 (AUTHOR) rms72@cam.ac.uk
Publikováno v: Scientific Reports. 12/12/2024, Vol. 14 Issue 1, p1-5. 5p.
Zobrazit plný text záznamu
6
Akademický článek
Hypofunction of macrophage chemotaxis contributes to defective efficacy of herceptin in HER2-positive breast cancer patients.
Autor: Song, Yu1 (AUTHOR) songyugzyx@163.com, Geng, Qiao-Chen1 (AUTHOR), An, Wen-Jing1 (AUTHOR), Zhang, Fu-Cheng1 (AUTHOR), Jiang, Ran1 (AUTHOR), Zhao, Rui-Sheng1 (AUTHOR), Deng, Zhi-Jian1 (AUTHOR), Li, Heng2 (AUTHOR) cpuliheng@gmail.com
Publikováno v: Molecular & Cellular Oncology. 2024, Vol. 11 Issue 1, p1-11. 11p.
Zobrazit plný text záznamu
7
Akademický článek
Characterization of Loss-of-Imprinting in Breast Cancer at the Cellular Level by Integrating Single-Cell Full-Length Transcriptome with Bulk RNA-Seq Data.
Autor: Amin, Muhammad Talal1,2,3 (AUTHOR) muhammadtalal.amin@ugent.be, Coussement, Louis1,2 (AUTHOR) louis.coussement@ugent.be, De Meyer, Tim1,2,4 (AUTHOR) tim.demeyer@ugent.be
Publikováno v: Biomolecules (2218-273X). Dec2024, Vol. 14 Issue 12, p1598. 14p.
Zobrazit plný text záznamu
8
Akademický článek
Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer.
Autor: Er, Idris1 (AUTHOR) idriser@ktu.edu.tr, Boz Er, Asiye Busra2 (AUTHOR) asiyebusra.bozer@erdogan.edu.tr
Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12102. 11p.
Zobrazit plný text záznamu
9
Akademický článek
Poly(Epsilon-Lysine) Dendrons Inhibit Proliferation in HER2-Overexpressing SKBR3 Breast Cancer Cells at Levels Higher than the Low-Expressing MDA-MB-231 Phenotype and Independently from the Presentation of HER2 Bioligands in Their Structure.
Autor: Peregrino, Giordana M. S.1 (AUTHOR) peregrino.giordana@gmail.com, Kudsiova, Laila1,2 (AUTHOR) l.kudsiova@bham.ac.uk, Santin, Matteo1 (AUTHOR) m.santin@brighton.ac.uk
Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11987. 19p.
Zobrazit plný text záznamu
10
Akademický článek
Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru: Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections.
Autor: Figallo, Miguel1 (AUTHOR) mfigallo@apoyoconsultoria.com, Delgado, María F.2 (AUTHOR), Gonzalez, Mauricio1 (AUTHOR), Arenas, Adrián3 (AUTHOR)
Publikováno v: PLoS ONE. 11/11/2024, Vol. 19 Issue 11, p1-15. 15p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje